Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Next Science Limited
  6. News
  7. Summary
    NXS   AU0000041329

NEXT SCIENCE LIMITED

(NXS)
  Report
Delayed Australian Stock Exchange  -  02:11 2022-08-12 am EDT
0.9250 AUD   -1.60%
07/25NEXT SCIENCE : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27TRANSCRIPT : Next Science Limited - Shareholder/Analyst Call
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Transcript : Next Science Limited - Shareholder/Analyst Call

11/17/2020 | 06:00pm EDT
share with twitter
share with LinkedIn
share with facebook
Ladies and gentlemen, thank you for standing by, and welcome to Next Science Limited's General Meeting. I would now like to hand the conference over to your first speaker today, Chairman, George...


© S&P Capital IQ 2020
All news about NEXT SCIENCE LIMITED
07/25NEXT SCIENCE : Investor Presentation - Q2 2022
PU
05/27Next Science CEO to Resign Before June 30, 2023
MT
05/27TRANSCRIPT : Next Science Limited - Shareholder/Analyst Call
CI
05/26Next Science Limited's Judith Mitchell to Step Down as Chief Executive Officer
CI
05/19Next Science Secures Australia, New Zealand Distributor for Wound Dressing Product
MT
05/18Next Science Limited Signed Multi-Year Distribution Agreement with Oraderm Pharmaceutic..
CI
05/10New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both..
BU
05/10Next Science Xperience(Tm) No Rinse Solution Shows Persistent Efficacy Against Both Pla..
CI
04/28Australian Shares End Three-Day Losing Streak on Boost from Miners
MT
04/27Next Science Posts 31% Growth in Q1 Product Revenue
MT
More news
Financials (USD)
Sales 2022 16,4 M - -
Net income 2022 -6,06 M - -
Net cash 2022 11,7 M - -
P/E ratio 2022 -16,7x
Yield 2022 -
Capitalization 141 M 141 M -
EV / Sales 2022 7,91x
EV / Sales 2023 4,21x
Nbr of Employees -
Free-Float 51,2%
Chart NEXT SCIENCE LIMITED
Duration : Period :
Next Science Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEXT SCIENCE LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 0,66 $
Average target price 1,35 $
Spread / Average Target 105%
EPS Revisions
Managers and Directors
Judith Mitchell Chief Executive Officer, Director & MD
Jacqueline Butler Chief Financial Officer
Mark R. Compton Non-Executive Chairman
Matthew Myntti Chief Technology Officer
Jon Swanson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
NEXT SCIENCE LIMITED-25.70%144
JOHNSON & JOHNSON-2.30%439 441
ELI LILLY AND COMPANY9.03%286 164
ROCHE HOLDING AG-18.19%272 759
PFIZER, INC.-18.22%271 020
ABBVIE INC.4.93%251 211